The Modernization of Cosmetics Regulation Act (MoCRA), signed into law December 29, 2022, is the most significant update to US cosmetics regulation in over 85 years. For the first time, FDA has mandatory authority over cosmetic facility registration, product listing, safety records, and adverse event reporting.
If your company manufactures, processes, or markets cosmetics in the United States — including foreign companies exporting to the US — MoCRA compliance is now a legal requirement, not optional.
No — MoCRA created a separate cosmetic facility registration system. Cosmetics-only facilities register specifically as cosmetic manufacturers under MoCRA, not under the food facility registration system.
Yes. Foreign facilities that manufacture or process cosmetics for US sale must register with FDA. You will also need to designate a US Agent or responsible person for FDA communications.
Serious adverse events include those that result in death, a life-threatening experience, inpatient hospitalization, persistent or significant disability, congenital anomaly, or require medical or surgical intervention.
Safety substantiation means maintaining adequate data and information to support the safety of your cosmetic product under its intended and reasonably foreseeable conditions of use. FDA does not pre-approve this — but can request your records at any time.
Small businesses with average annual gross sales of cosmetics under $1 million (using the 3-year average) are exempt from facility registration and product listing, with some exceptions (e.g., products that come into contact with mucous membranes or eyes).